Table 1 Clinicopathological correlation of ARNTL2 expression in human ccRCC
Characteristic | Low expression of ARNTL2 | High expression of ARNTL2 | pa |
|---|---|---|---|
n | 269 | 270 | Â |
Age, n (%) | Â | Â | 0.518 |
 <=60 | 130 (24.1%) | 139 (25.8%) |  |
 >60 | 139 (25.8%) | 131 (24.3%) |  |
Gender, n (%) | Â | Â | 0.903 |
 Female | 94 (17.4%) | 92 (17.1%) |  |
 Male | 175 (32.5%) | 178 (33%) |  |
T stage, n (%) | Â | Â | 0.027 |
 T1–T2 | 183 (33.9%) | 166 (30.8%) |  |
 T3–T4 | 86 (16%) | 95 (19.3%) |  |
N stage, n (%) | Â | Â | 0.034 |
 N0 | 119 (46.3%) | 122 (47.5%) |  |
 N1 | 3 (1.2%) | 13 (5.1%) |  |
M stage, n (%) | Â | Â | 0.118 |
 M0 | 220 (43.5%) | 208 (41.1%) |  |
 M1 | 32 (6.3%) | 46 (9.1%) |  |
Pathologic stage, n (%) | Â | Â | 0.031 |
 Stage I–II | 174 (32.5%) | 157 (29.3%) |  |
 Stage III–IV | 95 (17.7%) | 110 (20.6%) |  |
Histologic grade, n (%) | Â | Â | 0.012 |
 G1–3 | 233 (43.9%) | 223 (42%) |  |
 G4 | 31 (5.8%) | 44 (8.3%) |  |